Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR2 | P30874 | 13/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7699514 | 0.86 | KDM4E (0.44) | KDM4EMEN1ALDH1A1HPGDKMT2A | |
| SCHEMBL8634529 | 0.86 | KDM4E (0.44) | KDM4EMEN1ALDH1A1HPGDKMT2A | |
| SCHEMBL8366928 | 0.86 | SSTR2 (0.33) | SSTR2KDM4EMEN1ALDH1A1HPGD | |
| SCHEMBL5166402 | 0.76 | — | — | |
| SCHEMBL7608350 | 0.75 | ALDH1A1 (0.45) | SSTR2KDM4EMEN1ALDH1A1HPGD | |
| SCHEMBL7608326 | 0.75 | ALDH1A1 (0.45) | SSTR2KDM4EMEN1ALDH1A1HPGD | |
| SCHEMBL7610667 | 0.75 | ALDH1A1 (0.45) | SSTR2KDM4EMEN1ALDH1A1HPGD | |
| Hydrochloric Acid SCHEMBL7608719 | 0.74 | ALDH1A1 (0.46) | SSTR2KDM4EMEN1ALDH1A1HPGD | |
| Hydrochloric Acid SCHEMBL7615492 | 0.74 | ALDH1A1 (0.46) | SSTR2KDM4EMEN1ALDH1A1HPGD | |
| SCHEMBL8319831 | 0.74 | ALDH1A1 (0.47) | KDM4EMEN1ALDH1A1HPGDKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0946176-A1 | THE USE OF 7-(2-OXA-5,8-DIAZABICYCLO 4.3.0]NON-8-YL)-QUINOLONE CARBOXYLIC ACID AND NAPHTHYRIDON CARBOXYLIC ACID DERIVATIVES FOR THE TREATMENT OF HELICOBACTER PYLORI INFECTIONS AND ASSOCIATED GASTRODUODENAL DISEASES | BAYER AG (DE) | 1999-10-06 | — | — | EP | disclosed |
| WO-1998026779-A1 | THE USE OF 7-(2-OXA-5,8-DIAZABICYCLO[4.3.0]NON-8-YL)-QUINOLONE CARBOXYLIC ACID AND NAPHTHYRIDON CARBOXYLIC ACID DERIVATIVES FOR THE TREATMENT OF HELICOBACTER PYLORI INFECTIONS AND ASSOCIATED GASTRODUODENAL DISEASES | BAYER AKTIENGESELLSCHAFT (DE) | 1998-06-25 | — | — | WO | disclosed |